GE HealthCare
GEHC · Health Care Equipment
$71.45
0.0%Stryker
SYK · Health Care Equipment
$307.15
0.0%The short version
- Stryker is the larger business, with $25.1B of revenue in fiscal 2025 against $20.6B for GE HealthCare.
- Stryker grew revenue faster (11.2%, against 4.8%).
- Stryker kept more of each dollar of sales as operating profit (19.5% operating margin, against 13.4% operating margin).
- Stryker turned more of its sales into free cash flow (17.1% FCF margin, against 7.3% FCF margin).
- GE HealthCare earned a higher return on the capital invested in it (13.3%, against 11.3%).
- Investors pay more for each dollar of Stryker’s earnings: a P/E of 31.8x against 17.1x for GE HealthCare.
| Latest fiscal year | GEHC · FY25 | SYK · FY25 |
|---|---|---|
| Size | ||
| Market cap | $32.7B | $118.6B |
| Revenue | $20.6B | $25.1B |
| Free cash flow | $1.5B | $4.3B |
| Net income | $2.1B | $3.2B |
| Growth | ||
| Revenue growth | 4.8% | 11.2% |
| 5-year growth | — | 11.8% |
| Share count change | −0.2% | 0.2% |
| Profitability | ||
| Gross margin | 40.0% | 64.0% |
| Operating margin | 13.4% | 19.5% |
| Net margin | 10.1% | 12.9% |
| FCF margin | 7.3% | 17.1% |
| Return on capital | 13.3% | 11.3% |
| Return on equity | 22.1% | 15.1% |
| Balance sheet | ||
| Net debt | $6.0B | $10.8B |
| Net debt / EBITDA | 1.8x | 1.7x |
| Dividends and buybacks | $264M | $1.3B |
| Valuation & quality | ||
| P/E | 17.1x | 31.8x |
| Piotroski F-score | 7 | 6 |
FY16
GEHC —
SYK $11.3B
FY17
GEHC —
SYK $12.4B
FY18
GEHC —
SYK $13.6B
FY19
GEHC —
SYK $14.9B
FY20
GEHC —
SYK $14.4B
FY21
GEHC $17.6B
SYK $17.1B
FY22
GEHC $18.3B
SYK $18.4B
FY23
GEHC $19.6B
SYK $20.5B
FY24
GEHC $19.7B
SYK $22.6B
FY25
GEHC $20.6B
SYK $25.1B
GEHC
SYK
FY16
GEHC —
SYK 19.2%
FY17
GEHC —
SYK 18.5%
FY18
GEHC —
SYK 18.7%
FY19
GEHC —
SYK 18.2%
FY20
GEHC —
SYK 15.5%
FY21
GEHC 15.9%
SYK 15.1%
FY22
GEHC 13.8%
SYK 15.4%
FY23
GEHC 12.5%
SYK 19.0%
FY24
GEHC 13.3%
SYK 16.3%
FY25
GEHC 13.4%
SYK 19.5%
GEHC
SYK
FY16
GEHC —
SYK $1.4B
FY17
GEHC —
SYK $961M
FY18
GEHC —
SYK $2.0B
FY19
GEHC —
SYK $1.5B
FY20
GEHC —
SYK $2.8B
FY21
GEHC $1.4B
SYK $2.7B
FY22
GEHC $1.8B
SYK $2.0B
FY23
GEHC $1.7B
SYK $3.1B
FY24
GEHC $1.6B
SYK $3.5B
FY25
GEHC $1.5B
SYK $4.3B
GEHC
SYK
FY16
GEHC —
SYK 17.4%
FY17
GEHC —
SYK 8.5%
FY18
GEHC —
SYK 16.6%
FY19
GEHC —
SYK 12.5%
FY20
GEHC —
SYK 8.7%
FY21
GEHC —
SYK 9.5%
FY22
GEHC —
SYK 9.8%
FY23
GEHC 10.7%
SYK 12.7%
FY24
GEHC 13.4%
SYK 11.4%
FY25
GEHC 13.3%
SYK 11.3%
GEHC
SYK
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.